If you need an accessible version of this item please contact JSTOR User Support

Surveillance of Hospital-Acquired Central Line–Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients: Lessons Learned, Challenges Ahead

Aditya H. Gaur MD MSc, David G. Bundy MD MPH, Cuilan Gao PhD, Eric J. Werner MD MMM, Amy L. Billett MD, Jeff D. Hord MD, Jane D. Siegel MD, David Dickens MD, Cindi Winkle RN CPON, Marlene R. Miller MD MSc and Children’s Hospital Association Hematology-Oncology Quality Transformation Collaborative Project
Infection Control and Hospital Epidemiology
Vol. 34, No. 3 (March 2013), pp. 316-320
DOI: 10.1086/669513
Stable URL: http://www.jstor.org/stable/10.1086/669513
Page Count: 5
  • Download PDF
  • Cite this Item

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support
Surveillance of Hospital-Acquired Central Line–Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients: Lessons Learned, Challenges Ahead
Preview not available

Abstract

Across 36 US pediatric oncology centers, 576 central line–associated bloodstream infections (CLABSIs) were reported over a 21-month period. Most infections occurred in those with leukemia and/or profound neutropenia. The contribution of viridans streptococci infections was striking. Study findings depict the contemporary epidemiology of CLABSIs in hospitalized pediatric cancer patients.

Page Thumbnails